Stevanato Group S.p.A. (NYSE:STVN) Short Interest Update

Stevanato Group S.p.A. (NYSE:STVNGet Free Report) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 2,620,000 shares, a decrease of 14.9% from the May 31st total of 3,080,000 shares. Based on an average daily trading volume, of 655,600 shares, the short-interest ratio is presently 4.0 days. Approximately 5.3% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on STVN shares. Stephens reissued an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a report on Monday, March 25th. Morgan Stanley reissued an “equal weight” rating and set a $30.00 price target on shares of Stevanato Group in a report on Monday, April 22nd. Finally, BNP Paribas started coverage on shares of Stevanato Group in a report on Monday, April 22nd. They set an “outperform” rating for the company. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of €34.17 ($36.74).

Get Our Latest Report on Stevanato Group

Institutional Trading of Stevanato Group

Large investors have recently modified their holdings of the business. SRS Capital Advisors Inc. boosted its position in Stevanato Group by 327.1% during the fourth quarter. SRS Capital Advisors Inc. now owns 1,593 shares of the company’s stock worth $43,000 after acquiring an additional 1,220 shares during the last quarter. PNC Financial Services Group Inc. acquired a new stake in Stevanato Group during the third quarter worth approximately $60,000. Fifth Third Bancorp boosted its position in Stevanato Group by 62.1% during the fourth quarter. Fifth Third Bancorp now owns 4,009 shares of the company’s stock worth $109,000 after acquiring an additional 1,536 shares during the last quarter. First Horizon Advisors Inc. boosted its position in Stevanato Group by 14.1% during the fourth quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock worth $145,000 after acquiring an additional 657 shares during the last quarter. Finally, Jag Capital Management LLC acquired a new stake in Stevanato Group during the third quarter worth approximately $209,000.

Stevanato Group Stock Up 2.1 %

STVN traded up €0.39 ($0.42) on Monday, hitting €18.73 ($20.14). 498,000 shares of the company were exchanged, compared to its average volume of 483,109. The company has a current ratio of 1.92, a quick ratio of 1.35 and a debt-to-equity ratio of 0.21. The business’s fifty day moving average is €21.12 and its 200 day moving average is €26.78. Stevanato Group has a fifty-two week low of €16.56 ($17.81) and a fifty-two week high of €36.30 ($39.03).

Stevanato Group (NYSE:STVNGet Free Report) last issued its earnings results on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). Stevanato Group had a return on equity of 12.61% and a net margin of 12.57%. The company had revenue of €256.24 million for the quarter, compared to analyst estimates of €261.28 million. Equities analysts forecast that Stevanato Group will post 0.54 EPS for the current fiscal year.

Stevanato Group Announces Dividend

The firm also recently declared an annual dividend, which will be paid on Monday, July 15th. Stockholders of record on Tuesday, June 4th will be given a $0.053 dividend. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a dividend yield of 0.29%.

Stevanato Group Company Profile

(Get Free Report)

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Read More

Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.